Weiwei Jiao , Jie Wang , Cuidan Li , Peihan Wang , Sihong Xu , Jing Bi , Liya Yue , Fang Liu , Lin Sun , Hui Qi , Tingting Jiang , Xue Tian , He Tang , Xu Li , Min Li , Xuemei Yang , Xiaoxuan Yang , Yuting Sun , Haitao Niu , Wenbao Zhang , Fei Chen
{"title":"Genetic factors driving the Mycoplasma pneumoniae outbreak among children post-COVID-19 in China: a whole genome analysis","authors":"Weiwei Jiao , Jie Wang , Cuidan Li , Peihan Wang , Sihong Xu , Jing Bi , Liya Yue , Fang Liu , Lin Sun , Hui Qi , Tingting Jiang , Xue Tian , He Tang , Xu Li , Min Li , Xuemei Yang , Xiaoxuan Yang , Yuting Sun , Haitao Niu , Wenbao Zhang , Fei Chen","doi":"10.1016/j.lanwpc.2025.101578","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><em>Mycoplasma pneumoniae (M. pneumoniae)</em> is a leading cause of community-acquired pneumonia in children. Post-COVID-19, a significant resurgence of <em>M. pneumoniae</em> infections has been observed in China, but whole-genome analyses on the genetic mechanisms driving this resurgence remain limited.</div></div><div><h3>Methods</h3><div>We performed whole-genome sequencing on 169 <em>M. pneumoniae</em> isolates from Beijing and Baoding, collected before and after COVID-19. All <em>M. pneumoniae</em> genomes from GenBank were included for analysis. Genotypes were identified using multilocus variable-number tandem-repeat analysis (MLVA), multilocus sequence typing (MLST), phylogenetic analysis. Genomic conservation and transmission patterns were assessed via SNP distance.</div></div><div><h3>Findings</h3><div>We identified a post-COVID-19 resurgence of <em>M. pneumoniae</em> infections among children, with infection rates peaking at 60%–70% in late 2023, higher than during the pandemic (10%–20%) and pre-pandemic (∼30%). Genomic analysis revealed distinct genotypes, with T1-2 (4-5-7-2) dominating in Beijing, and both T1-2 and T2-2 (3-5-6-2) prevalent in Baoding. Minimal SNP distances and genomic conservation indicated rapid spread of <em>M. pneumoniae</em>. Genomic analysis uncovered key genetic factors driving the outbreak: near-100% macrolide resistance and increased prevalence of the 4-5-7-2 genotype (enriched in virulence and metabolism-related genes).</div></div><div><h3>Interpretation</h3><div>This study provides a comprehensive genomic analysis of genetic factors driving the outbreak. With near-100% macrolide resistance in China, urgent changes in treatment policies are needed. The rising prevalence of 4-5-7-2 and its functional advantages warrant close monitoring. Our findings offer insights into the outbreak causes and guide future prevention and control strategies.</div></div><div><h3>Funding</h3><div><span>National Key R&D Program of China</span>; Training Plan for <span>High level Public Health Technical Talents</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"59 ","pages":"Article 101578"},"PeriodicalIF":7.6000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606525001154","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Mycoplasma pneumoniae (M. pneumoniae) is a leading cause of community-acquired pneumonia in children. Post-COVID-19, a significant resurgence of M. pneumoniae infections has been observed in China, but whole-genome analyses on the genetic mechanisms driving this resurgence remain limited.
Methods
We performed whole-genome sequencing on 169 M. pneumoniae isolates from Beijing and Baoding, collected before and after COVID-19. All M. pneumoniae genomes from GenBank were included for analysis. Genotypes were identified using multilocus variable-number tandem-repeat analysis (MLVA), multilocus sequence typing (MLST), phylogenetic analysis. Genomic conservation and transmission patterns were assessed via SNP distance.
Findings
We identified a post-COVID-19 resurgence of M. pneumoniae infections among children, with infection rates peaking at 60%–70% in late 2023, higher than during the pandemic (10%–20%) and pre-pandemic (∼30%). Genomic analysis revealed distinct genotypes, with T1-2 (4-5-7-2) dominating in Beijing, and both T1-2 and T2-2 (3-5-6-2) prevalent in Baoding. Minimal SNP distances and genomic conservation indicated rapid spread of M. pneumoniae. Genomic analysis uncovered key genetic factors driving the outbreak: near-100% macrolide resistance and increased prevalence of the 4-5-7-2 genotype (enriched in virulence and metabolism-related genes).
Interpretation
This study provides a comprehensive genomic analysis of genetic factors driving the outbreak. With near-100% macrolide resistance in China, urgent changes in treatment policies are needed. The rising prevalence of 4-5-7-2 and its functional advantages warrant close monitoring. Our findings offer insights into the outbreak causes and guide future prevention and control strategies.
Funding
National Key R&D Program of China; Training Plan for High level Public Health Technical Talents.
期刊介绍:
The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.